Marina Biotech Receives Milestone Payment From SMARTICLES Licensee MiNA Therapeutics
November 17, 2015 08:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Nov 17, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported that it...
Marina Biotech Announces Third Quarter 2015 Financial Results
November 16, 2015 17:00 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Nov 16, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported financial...
Marina Biotech Reports That Licensee ProNAi Therapeutics Initiates 'Brighton' Phase II Trial of PNT2258 in Patients With Richter's Transformation
November 03, 2015 08:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Nov 3, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported that its...
Marina Biotech and Hongene Biotechnology Announce License Agreement
September 28, 2015 08:30 ET
|
Marina Biotech, Inc.
SHANGHAI, CHINA and BOTHELL, WA--(Marketwired - Sep 28, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases and...
Marina Biotech Announces Second Quarter 2015 Financial Results
August 13, 2015 17:00 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Aug 13, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported...
Marina Biotech Announces $1.1 MM Convertible Preferred Stock Financing
August 06, 2015 08:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Aug 6, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announced that the...
Marina Biotech's CEQ508 Granted FDA Fast Track Designation for Familial Adenomatous Polyposis
August 05, 2015 16:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Aug 5, 2015) - Marina Biotech, Inc. (OTCQB: MRNA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CEQ508, an...
Marina Biotech Expands European and Canadian Patent Protection of Its SMARTICLES Nucleic Acid Delivery Technology
June 10, 2015 08:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Jun 10, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announced that the...
Marina Biotech Announces First Quarter 2015 Financial Results
May 14, 2015 16:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - May 14, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported...
Marina Biotech Announces SMARTICLES(R)-Mediated Delivery of a Double-Stranded Oligonucleotide to Immune Cells
May 05, 2015 08:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - May 5, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today that its...